Barrett Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$218K Hold
1,680
0.01% 203
2021
Q4
$256K Hold
1,680
0.01% 196
2021
Q3
$272K Hold
1,680
0.01% 176
2021
Q2
$275K Hold
1,680
0.01% 167
2021
Q1
$253K Hold
1,680
0.01% 169
2020
Q4
$255K Hold
1,680
0.01% 160
2020
Q3
$227K Hold
1,680
0.01% 155
2020
Q2
$230K Hold
1,680
0.01% 145
2020
Q1
$181K Hold
1,680
0.01% 137
2019
Q4
$202K Hold
1,680
0.01% 151
2019
Q3
$167K Hold
1,680
0.01% 158
2019
Q2
$183K Hold
1,680
0.01% 154
2019
Q1
$188K Hold
1,680
0.01% 147
2018
Q4
$162K Hold
1,680
0.01% 152
2018
Q3
$205K Hold
1,680
0.01% 152
2018
Q2
$184K Hold
1,680
0.01% 157
2018
Q1
$179K Hold
1,680
0.01% 160
2017
Q4
$179K Hold
1,680
0.01% 159
2017
Q3
$187K Hold
1,680
0.01% 150
2017
Q2
$174K Hold
1,680
0.01% 152
2017
Q1
$164K Hold
1,680
0.01% 150
2016
Q4
$149K Hold
1,680
0.01% 152
2016
Q3
$162K Hold
1,680
0.01% 142
2016
Q2
$144K Hold
1,680
0.01% 152
2016
Q1
$146K Hold
1,680
0.01% 152
2015
Q4
$189K Hold
1,680
0.02% 140
2015
Q3
$170K Hold
1,680
0.02% 144
2015
Q2
$207K Hold
1,680
0.02% 145
2015
Q1
$192K Hold
1,680
0.02% 139
2014
Q4
$170K Hold
1,680
0.01% 171
2014
Q3
$153K Hold
1,680
0.01% 174
2014
Q2
$144K Buy
+1,680
New +$132K 0.01% 179

Other funds holding IBB

Barrett Asset Management's IBB Position: Q1 2022 in Review

Barrett Asset Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2022 at 1,680 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #203.

Barrett Asset Management first reported a position in IBB in Q2 2014 and has held it in 32 quarters since. The position peaked at $275K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • Barrett Asset Management held 1,680 shares of iShares Biotechnology ETF worth $218K as of Q1 2022.
  • Barrett Asset Management left its iShares Biotechnology ETF share count unchanged in Q1 2022.
  • iShares Biotechnology ETF made up 0.01% of Barrett Asset Management's portfolio in Q1 2022, its #203 holding.
  • Barrett Asset Management first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 32 quarters since.
  • Barrett Asset Management's iShares Biotechnology ETF position peaked at $275K in Q2 2021.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.